PODD Insulet Corp.

NASDAQ
$154.86

Insulet Corp. (PODD) is confirmed to report earnings on November 4, 2026, before the market open. The consensus earnings estimate is $1.59 per share.

Insulet Beat Expectations, Narrows Guidance
Wednesday, November 4, 2026 · 7:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 4
Wednesday · 7:00 AM ET
Earnings Whisper
$1.66
vs $1.59 +$0.07
Rev est $833.3M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $140.95

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Insulet Corp.

Insulet Corp is a medical device company that develops, manufactures and markets OmniPod Insulin Management System, an insulin infusion system for people with insulin-dependent diabetes.

Sector

Healthcare

Industry

Medical Appliances/Equipment

Held By 6 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.